Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tern plc ( (GB:TERN) ) just unveiled an update.
Tern Plc has announced that investor presentation materials from its recent online event featuring portfolio companies Device Authority and Talking Medicines are now available to view via published links, with a recording of the session to be hosted shortly on the company’s website. By making these detailed presentations and the event recording accessible, Tern is enhancing transparency and engagement with investors, offering deeper insight into the progress and prospects of its key IoT-focused holdings, which may help support stakeholder understanding of the portfolio’s development and strategic positioning.
The most recent analyst rating on (GB:TERN) stock is a Hold with a £0.68 price target. To see the full list of analyst forecasts on Tern plc stock, see the GB:TERN Stock Forecast page.
Spark’s Take on GB:TERN Stock
According to Spark, TipRanks’ AI Analyst, GB:TERN is a Neutral.
The score is held down primarily by very weak financial performance (sharp revenue contraction, heavy losses, and negative operating/free cash flow). Technicals provide some offset with positive momentum, but overbought signals increase downside risk. Valuation is also constrained by negative earnings (negative P/E) and no indicated dividend support.
To see Spark’s full report on GB:TERN stock, click here.
More about Tern plc
Tern Plc is an AIM-quoted investment company focused on supporting high-growth, early-stage, disruptive Internet of Things (IoT) technology businesses. Its portfolio includes companies such as Device Authority and Talking Medicines, which operate in specialised segments of the IoT and digital health ecosystems.
Average Trading Volume: 2,715,993
Technical Sentiment Signal: Sell
Current Market Cap: £4.71M
See more insights into TERN stock on TipRanks’ Stock Analysis page.

